HCV reinfection uncommon among people who inject drugsAugust 9, 2022Infectious DiseasesAddiction MedicineMixed TopicsHepatitis
High residual liver cancer risk in HCV-cured cirrhosisJuly 12, 2022OncologyInfectious DiseasesHepatitisAddiction Medicine
Unexplained hepatitis cases in children reported in 10 U.S. states, more than 200 worldwideMay 3, 2022Infectious DiseasesHepatitis
Postpartum HCV treatment rare in infected mothers with opioid use disorderApril 7, 2022Addiction MedicineWomen's HealthHepatitis
HCV screening in pregnancy: Reducing the risk for casualties in the quest for eliminationNovember 23, 2021Women's HealthInfectious DiseasesHepatitis
Antiviral Therapy Improves Hepatocellular Cancer SurvivalSeptember 3, 2021Hepatocellular CarcinomaHepatitisInfectious Diseases
Comparison of Renal Function Between Tenofovir Disoproxil Fumarate and Other Nucleos(t)ide Reverse Transcriptase Inhibitors in Patients With Hepatitis B Virus InfectionAugust 9, 2021Hepatitis
Treating Hepatitis C Virus Reinfection With 8 Weeks of Ledipasvir/Sofosbuvir Achieves Sustained Virologic ResponseJune 9, 2021HepatitisInfectious Diseases
HBV viremia linked to HCC risk in HIV/HBV coinfectionMarch 10, 2021HepatitisHIVInfectious DiseasesOncology
CDC: 20% of people in the U.S. are infected with an STDJanuary 27, 2021HIVHepatitisInfectious DiseasesMixed Topics
Eliminating hepatitis by 2030: HHS releases new strategic planJanuary 15, 2021HepatitisInfectious DiseasesHealth Policy
